UNIGE document Scientific Article
previous document  unige:31384  next document
add to browser collection

Essais thérapeutiques dans la dystrophie musculaire de Duchenne: entre espoirs et désespoirs

Bloetzer, Clemens
Published in Revue médicale suisse. 2012, vol. 8, no. 329, p. 409-12
Abstract Duchenne muscular dystrophy is an X-linked progressive muscle disease. Since the discovery of the dystrophin gene responsible for the condition, various therapeutic strategies have been elaborated. In this paper we introduce three of them, which are well into clinical trials. The first is based on the ability to read through premature stop codons, the second is based on the technique of exon skipping. Both strategies are examples of "personalized medicines", tailored for specific mutation types. The third approach is a pharmacological one, potentially useful for all Duchenne patients, regardless of their mutation type. These first clinical trials raise many questions for researchers as well as for patients and their families, some of which are discussed.
Keywords ChildGenetic TherapyHumansMuscular Dystrophy, Duchenne/drug therapy/genetics
PMID: 22432241
Full text
Article (Published version) (603 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-329-page-409.htm
Research group Groupe Menache Starobinski Caroline (881)
(ISO format)
BLOETZER, Clemens, FLUSS, Joel Victor, JEANNET, Pierre-Yves. Essais thérapeutiques dans la dystrophie musculaire de Duchenne: entre espoirs et désespoirs. In: Revue médicale suisse, 2012, vol. 8, n° 329, p. 409-12. https://archive-ouverte.unige.ch/unige:31384

357 hits

0 download


Deposited on : 2013-11-27

Export document
Format :
Citation style :